Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,328,968
+$289,628 QoQ
Shares Held
1,108
-1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#2,866
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONARCH CAPITAL MANAGEMENT INC holds $54,521,424 across 10 Drug Manufacturers - General names. LLY ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
119,322 | $15,332,877 | |
| 2 | JNJ |
Johnson & Johnson
|
57,752 | $14,667,275 | |
| 3 | ABBV |
AbbVie Inc.
|
49,047 | $12,342,187 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
40,685 | $5,140,142 | |
| 5 | PFE |
Pfizer Inc
|
127,572 | $3,071,933 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
23,815 | $1,372,220 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
1,108 | $1,328,968 | |
| 8 | NVO |
Novo Nordisk A S
|
16,150 | $774,231 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,328,968 | 1,108 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,039,340 | 1,130 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $1,246,628 | 1,160 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $998,767 | 1,309 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,262,059 | 1,619 | Shares | Sole | 2025-08-20 | |
| 2025-03-31 | $1,134,800 | 1,374 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,056,096 | 1,368 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,029,462 | 1,162 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $1,052,051 | 1,162 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $882,984 | 1,135 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $648,207 | 1,112 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $604,808 | 1,126 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $551,520 | 1,176 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $403,861 | 1,176 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $544,735 | 1,489 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $481,468 | 1,489 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $495,747 | 1,529 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $443,587 | 1,549 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $427,864 | 1,549 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $357,896 | 1,549 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $385,364 | 1,679 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $313,670 | 1,679 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $291,924 | 1,729 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $255,926 | 1,729 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $283,867 | 1,729 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $329,460 | 2,375 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||